These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3817616)

  • 1. [Dawn phenomenon].
    Corcos AP; Friedmann R; Lysy Y; Chowers I
    Harefuah; 1986 Nov; 111(10):295-9. PubMed ID: 3817616
    [No Abstract]   [Full Text] [Related]  

  • 2. [The dawn phenomenon could be due to nictemeral rhythms in the peripheral metabolism of insulin].
    Levy I; Bergua M; Recasens A; Gutiérrez A; Rodríguez MD; Vidal N; Capillas R; Goday A; Casamitjana R; Guillén M
    Med Clin (Barc); 1986 May; 87(1):6-9. PubMed ID: 3736203
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dawn phenomenon. Studies using artificial pancreas in insulin dependent diabetic patients].
    Rodríguez García MA; Gutiérrez López MA; Durán García S
    Med Clin (Barc); 1988 Jun; 91(3):81-2. PubMed ID: 3050312
    [No Abstract]   [Full Text] [Related]  

  • 4. The dawn phenomenon--fact or artefact?
    Gale EA
    Neth J Med; 1985; 28 Suppl 1():50-2. PubMed ID: 3892340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood sugar control in diabetic patients bearing microinfusors: the importance of the dawn phenomenon].
    Consoli A; Capani F; Vitacolonna E; Sensi S
    Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1685-9. PubMed ID: 6395872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with optimized therapy of insulin dependent diabetes mellitus using NovoPen].
    Carta G; Borgoglio A; Borgoglio MG; Granata L; Cordera R; Adezati L
    Clin Ter; 1988 Feb; 124(4):315-20. PubMed ID: 2974343
    [No Abstract]   [Full Text] [Related]  

  • 7. Fasting hyperglycemia in type I diabetes mellitus.
    Mozersky RP; Bahl VK; Patel H; Patel N; Palushock S; Yamakawa H; Mook W; Basuray R; Velez-Giraldo JR
    J Am Osteopath Assoc; 1993 Jul; 93(7):769-74. PubMed ID: 8365924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preprandial and postprandial variations of insulin sensitivity in different times of the day assessed by the artificial pancreas in type I diabetics.
    Trovati M; Bruno A; Lorenzati R; Caselle MT; Pagani A; Gorzegno G; Pagano G
    Chronobiologia; 1981; 8(4):333-40. PubMed ID: 7035094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rise at dawn. Why does blood glucose spike in the a.m.?
    Gebel E
    Diabetes Forecast; 2012 Mar; 65(3):28, 30. PubMed ID: 22439376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glucose-controlled insulin infusion systems (GCIIS, artificial pancreas) in therapy of diabetes mellitus and organic hyperinsulinism].
    Sailer D
    Verh Dtsch Ges Inn Med; 1987; 93():309-12. PubMed ID: 3442106
    [No Abstract]   [Full Text] [Related]  

  • 11. [The "dawn phenomenon" in diabetic patients].
    Kühnau J
    Dtsch Med Wochenschr; 1984 Sep; 109(38):1464-5. PubMed ID: 6479044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Optimized conventional insulin therapy].
    Capani F; Sensi S
    Recenti Prog Med; 1986 May; 77(5):249-56. PubMed ID: 3526462
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion: the insulin pump.
    De Nobel E
    Neth J Med; 1984; 27(5):173-6. PubMed ID: 6374480
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of insulin pumps for diabetes management.
    Webb KE
    Medsurg Nurs; 2006 Apr; 15(2):61-8, 94; quiz 69. PubMed ID: 16700243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of insulin-dependent diabetes mellitus].
    Fink RR
    MMW Munch Med Wochenschr; 1983 Jan; 125(3):96-9. PubMed ID: 6402679
    [No Abstract]   [Full Text] [Related]  

  • 16. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 17. [Optimum therapy of insulin-dependent diabetes mellitus].
    Sinagra D
    Recenti Prog Med; 1984 Sep; 75(9):823-32. PubMed ID: 6393244
    [No Abstract]   [Full Text] [Related]  

  • 18. [Type I diabetes mellitus: insulin treatment].
    Ryff AS; Berger W; Crausaz F
    Schweiz Med Wochenschr Suppl; 1994; 60():7-13. PubMed ID: 8016617
    [No Abstract]   [Full Text] [Related]  

  • 19. Human insulin and insulin pumps.
    Shuman CR
    Clin Ther; 1984; 6(4):380-7. PubMed ID: 6380721
    [No Abstract]   [Full Text] [Related]  

  • 20. The development of nephropathy in insulin-dependent diabetes mellitus is associated with poor glycemic control.
    Feldt-Rasmussen B
    Transplant Proc; 1994 Apr; 26(2):371-2. PubMed ID: 8171466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.